Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
1,806,796,154
-
Total 13F shares
-
780,508
-
Share change
-
+590,763
-
Total reported value
-
$513,183
-
Put/Call ratio
-
380%
-
Price per share
-
$0.66
-
Number of holders
-
17
-
Value change
-
+$392,637
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) as of Q4 2025
As of 31 Dec 2025,
PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
780,508 shares.
The largest 10 holders included
SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, SmartHarvest Portfolios, LLC, CITADEL ADVISORS LLC, BNP PARIBAS FINANCIAL MARKETS, TWO SIGMA ADVISERS, LP, SIMPLEX TRADING, LLC, RHUMBLINE ADVISERS, MORGAN STANLEY, and UBS Group AG.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.